Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine after total hip arthroplasty in patients with anxiety and depression
ChiCTR2000033605Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of duloxetine in major depressive disorder (MDD), anxiety disorder and postoperative pain (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: VAS pain score, Postoperative morphine consumption and 2 more. Started Jun 2020; status: recruiting.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)anxiety disorderpostoperative pain
Beyond the preview
Go deeper on ChiCTR2000033605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033605.